Arranta Bio is pleased to be among the top 50 second-stage companies in Florida selected as honorees in the 2020 GrowFL Florida Companies to Watch, a statewide competition that identifies companies expected to see significant growth over the next several years. The 2020 GrowFL Florida Companies to Watch awards celebration is brought to you by Nperspective CFO & Strategic Services, in association with the Edward Lowe Foundation.
Arranta Bio, a world-class CDMO supporting pioneers in the microbiome-based clinical space, was one of 82 finalists announced in September 2020; Fifty honorees were selected after a final round of judging by a panel of independent judges comprised of past honorees, economic development leaders and corporate partners of GrowFL. Companies were judged on a number of criteria including growth in the number of employees; the impact of the business in the job market; increase in sales and/or unit volume; current and past financial reports; innovativeness of the product or service; response to adversity; and contributions to aid community-oriented projects.
Arranta Bio acquired UF Innovate | The Hub resident client Captozyme, now Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for secondary hyperoxaluria.Learn more about Arranta Bio Named Honoree in GrowFL Companies to Watch.